Looking at the plotted significance of the S Line and Gann Square, we see a precise bounce in SP. Obviously this is all driven by PR but given the historical chart of $GEVO, indication of upside triple is imminent with awaiting plant licensing.
Per chart analysis plotted last month, $SRNE has landed exactly at the upswing mark highlighted in the red oval. 3 point meet with resistance and support, also considering Recent PR of President Biden's demand for mandated vaccination. The Gann Square thus far has proven its success at predicting price movement. Good luck all.
Here I take recent news to SP movement to provide accuracy of the Gann Square and S Line. Not in this stock just highlighting the tool usage and it’s abilities to predict price movement.
Considering the IPO within the last months, $ACXP has proven to investor its ability to hold value although its SP is not trading alike. Do not be fooled by the numbers, the company has had prior success with EUA and applications via FDA. Though private during inception, the company seeks to fund its ongoing pipeline with diversity. Their current target product...
Following up from the prior post published, the Gann Square has continued proving its accuracy with traders. Here i highlight the plots layed out from weeks ago that has set prime levels for support and resistance. As seen, the upward trend is ready to move past resistance and into its next level as the stock tested $9.63 . A nice withdrawal from RSI will assist...
Looking at the 6 month trend in Sorrento after its early year uptrend, the company has released back to back catalyst. However, FDA approval has been the majority in its probability to be valued. The gann square is showing no resistance as both horizontal lines since July have not crossed 50%, they are both currently within 12%, which states full support on its...
Noted in the trend band, $SENS has floated within its average for the last 3 months, with a small upward move from its initial 180 day CGM submission to the FDA. Although $SENS has report net loss, it is expected from a company within its product growth cycle. Additionally, new employees were hired to speed the R & D of its programming and engineering. New...
As earnings approach, expect HV as avg closes in near trend line. 3 weeks ago exited crossover. Trendline consistent w/ Pitchfork setting resistance, pivot and support for upside.
